{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:46:51Z","timestamp":1792514811389,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1245\/s10434-026-19476-6","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:01:26Z","timestamp":1774022486000},"page":"7732-7745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-0191","authenticated-orcid":false,"given":"Aleksander","family":"\u015alusarczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ca\u00f1o Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Daniel","family":"Subiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Garbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Del Olmo Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Claps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Doma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Grobet-Jeandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso Lafuente","family":"Puentedura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee A. G.","family":"Lijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Fertitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Marcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Afferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Albisinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Radziszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the European Association of Urology\u2014Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"19476_CR1","doi-asserted-by":"publisher","unstructured":"\u015alusarczyk A, Zapa\u0142a P, Zapa\u0142a \u0141, Borkowski T, Radziszewski P. Cancer-specific survival of patients with non-muscle-invasive bladder cancer: a population-based analysis. Ann Surg Oncol. 2023. https:\/\/doi.org\/10.1245\/s10434-023-14051-9","DOI":"10.1245\/s10434-023-14051-9"},{"issue":"4","key":"19476_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V, et al. European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel. Eur Urol. 2021;79(4):480\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.033.","journal-title":"Eur Urol"},{"issue":"9","key":"19476_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cancers16091684","volume":"16","author":"A \u015alusarczyk","year":"2024","unstructured":"\u015alusarczyk A, Garbas K, Pustu\u0142a P, Zapa\u0142a \u0141, Radziszewski P. Assessing the predictive accuracy of EORTC, CUETO and EAU risk stratification models for high-grade recurrence and progression after Bacillus Calmette-Gu\u00e9rin therapy in non-muscle-invasive bladder cancer. Cancers. 2024;16(9):9. https:\/\/doi.org\/10.3390\/cancers16091684.","journal-title":"Cancers"},{"key":"19476_CR4","doi-asserted-by":"publisher","unstructured":"Stephenson WT, Holmes FF, Noble MJ, Gerald KB. Analysis of bladder carcinoma by subsite. Cystoscopic location may have prognostic value. Cancer. 1990;66(7):1630-1635. https:\/\/doi.org\/10.1002\/1097-0142(19901001)66:7%3C1630::aid-cncr2820660730%3E3.0.co;2-7","DOI":"10.1002\/1097-0142(19901001)66:7%3C1630::aid-cncr2820660730%3E3.0.co;2-7"},{"issue":"2","key":"19476_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euf.2020.01.006","volume":"7","author":"H Fukushima","year":"2021","unstructured":"Fukushima H, Moriyama S, Waseda Y, et al. Significance of bladder neck involvement in risk substratification of intermediate-risk non-muscle-invasive bladder cancer. Eur Urol Focus. 2021;7(2):366\u201372. https:\/\/doi.org\/10.1016\/j.euf.2020.01.006.","journal-title":"Eur Urol Focus"},{"issue":"7","key":"19476_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1464-410X.2009.08525.x","volume":"104","author":"SG Patel","year":"2009","unstructured":"Patel SG, Cookson MS, Barocas DA, Clark PE, Smith JA, Chang SS. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. BJU Int. 2009;104(7):934\u20137. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08525.x.","journal-title":"BJU Int"},{"issue":"4","key":"19476_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.eururo.2016.09.035","volume":"71","author":"G Gakis","year":"2017","unstructured":"Gakis G, Black PC, Bochner BH, et al. Systematic review on the fate of the remnant urothelium after radical cystectomy. Eur Urol. 2017;71(4):545\u201357. https:\/\/doi.org\/10.1016\/j.eururo.2016.09.035.","journal-title":"Eur Urol"},{"key":"19476_CR8","doi-asserted-by":"publisher","unstructured":"Wright JL, Hotaling J, Porter MP. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis. J Urol. 2009;181(3):1035-1039; discussion 1039. https:\/\/doi.org\/10.1016\/j.juro.2008.10.168","DOI":"10.1016\/j.juro.2008.10.168"},{"issue":"3","key":"19476_CR9","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1245\/s10434-023-14710-x","volume":"31","author":"A \u015alusarczyk","year":"2024","unstructured":"\u015alusarczyk A, Zapa\u0142a P, Piecha T, Zapa\u0142a \u0141, Borkowski T, Radziszewski P. Upper urinary tract urothelial cancer after radical cystectomy for bladder cancer: survival outcomes after radical nephroureterectomy. Ann Surg Oncol. 2024;31(3):2144\u201353. https:\/\/doi.org\/10.1245\/s10434-023-14710-x.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"19476_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, Birtle A, Capoun O, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u2014A summary of the 2024 guidelines update. Eur Urol. 2024;86(6):531\u201349. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.027.","journal-title":"Eur Urol."},{"issue":"5","key":"19476_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000019636","volume":"33","author":"Y Fujii","year":"1998","unstructured":"Fujii Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998;33(5):464\u20138. https:\/\/doi.org\/10.1159\/000019636.","journal-title":"Eur Urol."},{"issue":"1","key":"19476_CR12","doi-asserted-by":"publisher","first-page":"38.e29","DOI":"10.1016\/j.urolonc.2013.04.001","volume":"32","author":"S Kobayashi","year":"2014","unstructured":"Kobayashi S, Fujii Y, Koga F, et al. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study. Urol Oncol. 2014;32(1):38.e29-36. https:\/\/doi.org\/10.1016\/j.urolonc.2013.04.001.","journal-title":"Urol Oncol"},{"issue":"5","key":"19476_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.urology.2014.05.011","volume":"84","author":"RS Svatek","year":"2014","unstructured":"Svatek RS, Clinton TN, Wilson CA, et al. Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy. Urology. 2014;84(5):1147\u201351. https:\/\/doi.org\/10.1016\/j.urology.2014.05.011.","journal-title":"Urology"},{"issue":"3","key":"19476_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","volume":"2","author":"AB Weiner","year":"2019","unstructured":"Weiner AB, Desai AS, Meeks JJ. Tumor location may predict adverse pathology and survival following definitive treatment for bladder cancer: a national cohort study. Eur Urol Oncol. 2019;2(3):304\u201310. https:\/\/doi.org\/10.1016\/j.euo.2018.08.018.","journal-title":"Eur Urol Oncol"},{"key":"19476_CR15","doi-asserted-by":"publisher","unstructured":"Scilipoti P, Longoni M, Angelis M de, et al. Long-term oncological outcomes for patients with non\u2013muscle-invasive bladder cancer treated with Bacillus Calmette\u2013Gu\u00e9rin (BCG): a comparative analysis of adequate versus inadequate BCG treatment. European Urology Focus. 2025. https:\/\/doi.org\/10.1016\/j.euf.2025.04.033","DOI":"10.1016\/j.euf.2025.04.033"},{"key":"19476_CR16","doi-asserted-by":"publisher","unstructured":"Longoni M, Scilipoti P, De Angelis M, et al. Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study. BJU International. n\/a(n\/a). https:\/\/doi.org\/10.1111\/bju.16780","DOI":"10.1111\/bju.16780"},{"key":"19476_CR17","doi-asserted-by":"publisher","unstructured":"\u015alusarczyk A, Garbas K, Zapa\u0142a P, Zapa\u0142a \u0141, Radziszewski P. Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians. Int Urol Nephrol. 2021. https:\/\/doi.org\/10.1007\/s11255-021-02870-2","DOI":"10.1007\/s11255-021-02870-2"},{"key":"19476_CR18","doi-asserted-by":"publisher","unstructured":"Stepp KJ, Walters MD. 2 - Anatomy of the lower urinary tract, rectum, and pelvic floor. In: Walters MD, Karram MM, eds. Urogynecology and Reconstructive Pelvic Surgery (Third Edition). Mosby; 2007:17-30. https:\/\/doi.org\/10.1016\/B978-0-323-02902-5.50008-3","DOI":"10.1016\/B978-0-323-02902-5.50008-3"},{"issue":"3","key":"19476_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11255-022-03447-3","volume":"55","author":"ME DeWitt-Foy","year":"2023","unstructured":"DeWitt-Foy ME, Anele UA, Accioly JPE, Sharpe MG, Michael P, Angermeier KW. Cancer risk in bladder diverticula: a large institutional analysis of risk and management. Int Urol Nephrol. 2023;55(3):541\u20136. https:\/\/doi.org\/10.1007\/s11255-022-03447-3.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"19476_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5173\/ceju.2024.103.R1","volume":"77","author":"O Zaytoun","year":"2024","unstructured":"Zaytoun O, Tillu N, Kolanukuduru K, et al. Thulium laser en bloc resection is a safe and efficacious alternative to conventional bipolar transurethral resection of bladder tumors. Cent European J Urol. 2024;77(3):466\u201371. https:\/\/doi.org\/10.5173\/ceju.2024.103.R1.","journal-title":"Cent European J Urol"},{"key":"19476_CR21","doi-asserted-by":"publisher","unstructured":"Gallagher K, MacLennan S, Bhatt N, et al. RESECT: a randomised controlled trial of audit and feedback in non-muscle-invasive bladder cancer surgery. Eur Urol. 2025:S0302-2838(25)04736-0. https:\/\/doi.org\/10.1016\/j.eururo.2025.09.4174","DOI":"10.1016\/j.eururo.2025.09.4174"},{"issue":"1","key":"19476_CR22","doi-asserted-by":"publisher","first-page":"9.e9","DOI":"10.1016\/j.urolonc.2021.05.006","volume":"40","author":"JD Subiela","year":"2022","unstructured":"Subiela JD, Faba \u00d3R, Aumatell J, et al. Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: lessons learned from long-term follow-up of a series of CIS patients treated with BCG. Urol Oncol. 2022;40(1):9.e9-9.e17. https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.006.","journal-title":"Urol Oncol"},{"issue":"1","key":"19476_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur Urol. 2016;69(1):60\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.045.","journal-title":"Eur Urol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19476-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:38:41Z","timestamp":1783345121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19476-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["19476"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19476-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gautier Marcq\u2014speaker for a pharmaceutical company: BMS, Merck, Johnson and Johnson, Astellas, and Engene; support from a pharmaceutical company for participation in a national or international congress: Bouchara Recordati, BMS, Merck, Johnson and Johnson, Ipsen, Astellas, and Photocure; consultant: Johnson and Johnson, BMS, Merck, and Merck Serono; principal investigator of a pharmaceutical industry trial: Merck, Johnson and Johnson, Fidia, Steba Biotech, and Engene.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}